Morgan Cheatham
InvestorFounderPartner and Head of Healthcare and Life Sciences at Breyer Capital · Board director at ParcelBio · Board director at Folx
New York, New York, United States
About
Morgan leads healthcare and life sciences investing at Breyer Capital, spanning software, therapeutics, diagnostics, and AI. He previously spent nearly a decade at Bessemer Venture Partners backing companies like Abridge and Hinge Health, and holds a B.S. and M.D. from Brown University.
Board director at ParcelBioYC W24
Intro paths
Morgan went through Y Combinator (Winter 2024) — any YC alum in your network can reach them through the YC community.
In turn, Morgan can intro founders to ParcelBio's investors below.
ParcelBio's investors · 10
Co-founders at ParcelBio
Board director at Folx
Intro paths
In turn, Morgan can intro founders to Folx's investors below.
Folx's investors · 9
Co-founders at Folx
.png)
Experience
- Breyer CapitalPartner and Head of Healthcare and Life Sciencescurrent2025 — present
- First Close PartnersLimited Partnercurrent2020 — presentNew York, New York, United States
- NEJM GroupNEJM AI Editorial Teamcurrent2023 — presentBoston, Massachusetts, United States
- Silver Beech Capital ManagementLimited Partnercurrent2023 — present
- Decoding BioCo-Founder2022 — 2026
- Bessemer Venture PartnersVice President2017 — 2025New York City Metropolitan Area
- National Human Genome Research Institute (NHGRI)Clinical and Research Student2024Bethesda, Maryland, United States
- Forbes30U302023
- Goldman SachsInvestment Banking Analyst2016Greater New York City Area
- KyruusData Scientist2015 — 2016Greater Boston Area
Education
- Harvard Medical SchoolPediatrics, Genetics & Genomics Fellowship
- The Warren Alpert Medical School of Brown UniversityDoctor of Medicine - MD
- Brown UniversityBachelor of Science (B.Sc.), Computational Decision Sciences
- Thomas Jefferson High School for Science and Technology
Skills & more
+12 more
Team LeadershipQuantitative FinanceInvestingMicrosoft OfficeMedical EducationQuality ImprovementHealth Information SystemsPhysiciansPatient SafetyNeuroscienceHospitalsPublic HealthLanguages Latin
From Morgan's professional profile.
Deals · 1
FolxBoard seat
via Breyer Capital · filed Oct 2022 · $30M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
Per SEC Form D filings.
Colleagues at Breyer Capital
Frequently asked questions
- Who is Morgan Cheatham?
- Morgan leads healthcare and life sciences investing at Breyer Capital, spanning software, therapeutics, diagnostics, and AI. He previously spent nearly a decade at Bessemer Venture Partners backing companies like Abridge and Hinge Health, and holds a B.S. and M.D. from Brown University.
- Where does Morgan Cheatham work?
- Morgan Cheatham is Partner and Head of Healthcare and Life Sciences at Breyer Capital and Board director at ParcelBio and Board director at Folx.
- What boards does Morgan Cheatham sit on?
- Morgan Cheatham holds tracked board seats at Folx, ParcelBio.
- Where did Morgan Cheatham go to school?
- Morgan Cheatham studied at Harvard Medical School (Pediatrics, Genetics & Genomics Fellowship); The Warren Alpert Medical School of Brown University (Doctor of Medicine - MD); Brown University (Bachelor of Science (B.Sc.), Computational Decision Sciences).
Same school
Also attended Harvard Medical School135
+ 129 more
Also attended The Warren Alpert Medical School of Brown University6
Also attended Brown University399
+ 393 more
Also attended Thomas Jefferson High School for Science and Technology52
+ 46 more
Shared employers
Also worked at NEJM Group3
Also worked at Decoding Bio4
Also worked at Bessemer Venture Partners147
+ 141 more

.png)

















.png)









.png)















.jpeg)


